TY - JOUR
T1 - Cytoreductive surgery for ovarian cancer
AU - Randall, T. C.
AU - Rubin, S. C.
PY - 2001
Y1 - 2001
N2 - Cytoreductive surgery is a crucial component of the management of cancer of the ovary. Surgical cytoreduction of ovarian cancer volume has been associated with an increase in survival in all settings in which it has been studied. This association seems strongest, and the benefits of aggressive surgery are generally greatest, in patients with chemosensitive disease. Effective surgical management of ovarian cancer, therefore, requires competence in surgical anatomy and cytoreductive techniques and a thorough understanding of the patient's disease status and therapeutic goals.
AB - Cytoreductive surgery is a crucial component of the management of cancer of the ovary. Surgical cytoreduction of ovarian cancer volume has been associated with an increase in survival in all settings in which it has been studied. This association seems strongest, and the benefits of aggressive surgery are generally greatest, in patients with chemosensitive disease. Effective surgical management of ovarian cancer, therefore, requires competence in surgical anatomy and cytoreductive techniques and a thorough understanding of the patient's disease status and therapeutic goals.
KW - Female
KW - Humans
KW - Ovarian Neoplasms/pathology
UR - http://www.scopus.com/inward/record.url?scp=0035194403&partnerID=8YFLogxK
UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=purepublist2023&SrcAuth=WosAPI&KeyUT=WOS:000170758400012&DestLinkType=FullRecord&DestApp=WOS
U2 - 10.1016/S0039-6109(05)70171-7
DO - 10.1016/S0039-6109(05)70171-7
M3 - Article
C2 - 11551131
SN - 0039-6109
VL - 81
SP - 871
EP - 883
JO - Surgical Clinics of North America
JF - Surgical Clinics of North America
IS - 4
ER -
